William Blair Issues Pessimistic Forecast for APLS Earnings
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – William Blair cut their Q2 2025 earnings per share estimates for shares of Apellis Pharmaceuticals in a report issued on Wednesday, May 7th. William Blair analyst L. Hanbury-Brown now anticipates that the company will earn ($0.52) per share for the quarter, down from their prior forecast of […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – William Blair cut their Q2 2025 earnings per share estimates for shares of Apellis Pharmaceuticals in a report issued on Wednesday, May 7th. William Blair analyst L. Hanbury-Brown now anticipates that the company will earn ($0.52) per share for the quarter, down from their prior forecast of […]
